X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (290) 290
cardiac & cardiovascular systems (191) 191
male (185) 185
heart failure (156) 156
female (150) 150
middle aged (149) 149
aged (122) 122
heart failure - drug therapy (90) 90
mortality (90) 90
heart failure - physiopathology (77) 77
chronic disease (53) 53
adult (52) 52
animals (50) 50
index medicus (49) 49
cardiac patients (48) 48
heart failure - mortality (45) 45
prognosis (44) 44
treatment outcome (43) 43
medicine, general & internal (42) 42
double-blind method (40) 40
drug therapy (40) 40
cardiology and cardiovascular medicine (37) 37
cardiovascular (37) 37
adrenergic beta-antagonists - therapeutic use (36) 36
follow-up studies (36) 36
care and treatment (33) 33
survival (33) 33
cardiology (31) 31
heart (30) 30
peripheral vascular disease (29) 29
angiotensin-converting enzyme inhibitors - therapeutic use (27) 27
morbidity (27) 27
prospective studies (27) 27
myocardial-infarction (26) 26
cardiovascular disease (25) 25
exercise (25) 25
left-ventricular dysfunction (25) 25
survival analysis (25) 25
exercise test (24) 24
heart failure - complications (24) 24
in vitro techniques (24) 24
patient outcomes (24) 24
rabbits (24) 24
risk factors (24) 24
heart failure - blood (23) 23
heart attacks (22) 22
myocardium - metabolism (22) 22
analysis (21) 21
angina pectoris (20) 20
carbazoles - therapeutic use (20) 20
congestive heart failure (20) 20
disease (20) 20
propanolamines - therapeutic use (20) 20
diagnosis (19) 19
electrocardiography (19) 19
heart failure - diagnosis (19) 19
hematology (19) 19
metoprolol - therapeutic use (19) 19
research (19) 19
time factors (19) 19
captopril (18) 18
heart failure - therapy (18) 18
metoprolol (18) 18
physiological aspects (18) 18
prevalence (18) 18
trial (18) 18
aged, 80 and over (17) 17
cardiac and cardiovascular systems (17) 17
cardiovascular system (17) 17
chronic heart failure (17) 17
kardiologi (17) 17
medical research (17) 17
randomized controlled trials as topic (17) 17
therapy (17) 17
abridged index medicus (16) 16
acute myocardial-infarction (16) 16
echocardiography (16) 16
enalapril (16) 16
heart failure - etiology (16) 16
hypertension (16) 16
oxygen consumption (16) 16
cardiomyopathy (15) 15
carvedilol (15) 15
clinical trials (15) 15
clinical trials as topic (15) 15
dysfunction (15) 15
heart diseases (15) 15
internal medicine (15) 15
proportional hazards models (15) 15
coronary disease - physiopathology (14) 14
dose-response relationship, drug (14) 14
epidemiology (14) 14
heart failure - metabolism (14) 14
hospitalization (14) 14
metabolism (14) 14
myocardial contraction - drug effects (14) 14
nifedipine (14) 14
randomized-trial (14) 14
diuretics - therapeutic use (13) 13
enzymes (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1991, Royal Brompton series., ISBN 9780750613354, xiv, 193
Book
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 04/2016, Volume 2016, Issue 4
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2009, Volume 361, Issue 25, pp. 2436 - 2448
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2008, Volume 52, Issue 20, p. 1649
  [...]if the result of a trial is to be applied globally, experience from centers in several continents is advisable. [...]of the greatest importance, there... 
Studies | Heart attacks | Mortality | Hospitalization | Drug therapy
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2009, Volume 53, Issue 23, pp. 2150 - 2158
Journal Article
Circulation, ISSN 0009-7322, 03/2006, Volume 113, Issue 11, pp. 1424 - 1433
Background - Heart failure has an annual mortality rate ranging from 5% to 75%. The purpose of the study was to develop and validate a multivariate risk model... 
Heart failure | Diuretics | Hemoglobin | Prognosis | Lymphocytes | MORTALITY | heart failure | CARDIAC & CARDIOVASCULAR SYSTEMS | lymphocytes | VALIDATION | RANDOMIZED-TRIAL | prognosis | hemoglobin | AMBULATORY PATIENTS | HIGH-RISK PATIENTS | THERAPY | CARDIAC-RESYNCHRONIZATION | MORBIDITY | diuretics | PERIPHERAL VASCULAR DISEASE | SYSTOLIC DYSFUNCTION | BETA-BLOCKERS | HEMATOLOGY | Heart Failure - surgery | Ventricular Dysfunction, Left - surgery | Heart-Assist Devices - utilization | Multivariate Analysis | Prospective Studies | Follow-Up Studies | Area Under Curve | Humans | Middle Aged | Ventricular Dysfunction, Left - complications | Male | Life Expectancy | Aged, 80 and over | Adult | Female | Heart Failure - etiology | Heart Failure - mortality | Randomized Controlled Trials as Topic - statistics & numerical data | Comorbidity | Models, Cardiovascular | Defibrillators, Implantable - utilization | Proportional Hazards Models | Survival Rate | Treatment Outcome | Combined Modality Therapy | Cardiac Pacing, Artificial - utilization | Forecasting | Heart Failure - drug therapy | Cardiovascular Agents - therapeutic use | Ventricular Dysfunction, Left - drug therapy | Survival Analysis | Lymphocyte Count | Diuretics - therapeutic use | ROC Curve | Aged | Diuretics - adverse effects | Hemoglobins - analysis | Cohort Studies
Journal Article
by Thygesen, Kristian and Alpert, Joseph S and White, Harvey D and ESC ACCF AHA WHF Task Force and Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction and Biomarker Group: Allan S. Jaffe, Coordinator (USA), Fred S. Apple (USA), Marcello Galvani (Italy), Hugo A. Katus (Germany), L. Kristin Newby (USA), Jan Ravkilde (Denmark) and ECG Group: Bernard Chaitman, Co-ordinator (USA), Peter M. Clemmensen (Denmark), Mikael Dellborg (Sweden), Hanoch Hod (Israel), Pekka Porela (Finland) and Global Perspective Group: Philip A. Poole-Wilson, Coordinator (UK), Enrique P. Gurfinkel (Argentina), José-Luis Lopez-Sendon (Spain), Prem Pais (India), Shanti Mendis (Switzerland), Jun-Ren Zhu (China) and ESC COMMITTEE FOR PRACTICE GUIDELINES and Implementation Group: Lars C. Wallentin Coordinator (Sweden), Francisco Fernández-Avilés (Spain), Kim M. Fox (UK), Alexander N. Parkhomenko (Ukraine), Silvia G. Priori (Italy), Michal Tendera (Poland), Liisa-Maria Voipio-Pulkki (Finland) and Imaging Group: Richard Underwood, Coordinator (UK), Jeroen J. Bax (The Netherlands), George A. Beller (USA), Robert Bonow (USA), Ernst E. Van Der Wall (The Netherlands) and Joao Morais, Review Coordinator (Portugal), Sorin Brener (USA), Robert Harrington (USA), David Morrow (USA), Udo Sechtem (Germany), Michael Lim (Singapore), Marco A. Martinez-Rios (Mexico), Steve Steinhubl (USA), Glen N. Levine (USA), W. Brian Gibler (USA), David Goff (USA), Marco Tubaro (Italy), Darek Dudek (Poland), Nawwar Al-Attar (France) and Alec Vahanian, Chair (France), A. John Camm (UK), Raffaele De Caterina (Italy), Veronica Dean (France), Kenneth Dickstein (Norway), Gerasimos Filippatos (Greece), Christian Funck-Brentano (France), Irene Hellemans (The Netherlands), Steen Dalby Kristensen (Denmark), Keith McGregor (France), Udo Sechtem (Germany), Sigmund Silber (Germany), Michal Tendera (Poland), Petr Widimsky (Czech Republic), José Luis Zamorano (Spain) and TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), Joseph S. Alpert (USA), Harvey D. White (New Zealand) and Intervention Group: Jean-Pierre Bassand, Co-ordinator (France), William Wijns, Coordinator (Belgium), T. Bruce Ferguson (USA), Philippe G. Steg (France), Barry F. Uretsky (USA), David O. Williams (USA) and Clinical Investigation Group: Paul W. Armstrong, Coordinator (Canada), Elliott M. Antman (USA), Keith A. Fox (UK), Christian W. Hamm (Germany), E. Magnus Ohman (USA), Maarten L. Simoons (The Netherlands) and DOCUMENT REVIEWERS and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Institutionen för medicinska vetenskaper
Circulation, ISSN 0009-7322, 11/2007, Volume 116, Issue 22, pp. 2634 - 2653
Journal Article